Syncom Share Price Target Tomorrow 2024 To 2030- Current Graph, market Overview

Syncom Formulations (India) Ltd is a pharmaceutical company that specializes in the production and distribution of a wide range of pharmaceutical products, including tablets, capsules, syrups, and ointments. Established in India, the company caters to both domestic and international markets. Syncom Share Price on NSE as of 15 October 2024 is 21.10 INR. Here will provide you more details on Syncom Share Price Target 2024, 2025, 2026 to 2030.

Syncom Formulations (India) Ltd: Market Overview

• Open Price: ₹21.28
• High Price: ₹21.33
• Low Price: ₹20.82
• Previous Close: ₹21.24
• Volume: 2,555,286
• Value (Lacs): ₹537.38
• VWAP: ₹21.02
• UC Limit: ₹23.36
• LC Limit: ₹19.11
• P/E ratio: 64.73
• Div yield: N/A
• 52-wk high: ₹27.90
• 52-wk low: ₹7.25
• Mkt cap: ₹1.98KCr
• Face Value: ₹1

Syncom Share Price Chart

Syncom Share Price Target Tomorrow 2024 To 2030

Syncom Share Price Target 2024

Syncom share price target 2024 Expected target could be ₹30. Here are three key factors that could affect the growth of Syncom Formulations’ share price in 2024:

• Expansion of Product Portfolio: Syncom’s ability to expand its product offerings, including new pharmaceutical formulations or innovative healthcare products, can drive its growth. A broader portfolio can increase market reach and attract more customers, which in turn boosts the share price.
• Regulatory Approvals and Compliance: Maintaining strict regulatory compliance and receiving approvals for new products can positively impact Syncom’s growth. Regulatory hurdles or delays, on the other hand, could slow down growth prospects.

• Market Demand for Generic Medicines: Syncom operates in the generic medicine sector, where increasing demand for affordable healthcare solutions, especially in emerging markets, could lead to revenue growth. A rising focus on healthcare accessibility could further push the company’s stock upwards.

Syncom Share Price Target 2025

Syncom share price target 2025 Expected target could be ₹41. Here are three key factors that could affect the growth of Syncom Formulations’ share price in 2025:

• Expansion into International Markets: Syncom’s ability to tap into new international markets will be a major driver of growth. If the company successfully expands its global footprint, particularly in emerging economies with rising healthcare demands, it could significantly boost revenues and share price.
• Research and Development (R&D) Investments: Increased investment in R&D for new drug formulations and healthcare products can be a key growth driver in 2025. A strong pipeline of innovative products can enhance Syncom’s market position and attract investor confidence.

• Strategic Partnerships and Collaborations: Forming strategic partnerships with other pharmaceutical companies, research institutions, or healthcare providers can enhance Syncom’s capabilities. Collaborations for technology sharing or product co-development may help the company grow faster, pushing up the share price.

Syncom Share Price Target 2030

Syncom share price target 2030 Expected target could be ₹93. Here are three key factors that could affect the growth of Syncom Formulations’ share price by 2030:

• Long-Term Market Penetration and Brand Recognition: By 2030, Syncom’s ability to establish a strong presence in both domestic and international markets will be critical. A consistent focus on enhancing brand recognition and maintaining market share in competitive regions will likely drive long-term growth in its share price.
• Regulatory Approvals and Compliance: As the pharmaceutical industry evolves, regulatory compliance will be crucial. If Syncom secures timely approvals for new drugs and formulations and meets global regulatory standards, it can boost investor confidence and contribute to its growth.

• Sustainability and Innovation in Healthcare Solutions: By 2030, the focus on sustainable and innovative healthcare solutions will be more pronounced. Syncom’s ability to introduce eco-friendly, affordable healthcare products that cater to future market demands could become a significant growth factor, influencing the company’s valuation and share price trajectory.

Shareholding Pattern For Syncom Formulations (India) Ltd

• Promoters: 50.57%
• FII: 0.09%
• DII: 0%
• Public: 49.34%

Syncom Formulations (India) Ltd Financials

Read Also:- Castrol India Share Price Target Tomorrow 2024 To 2030- Current Graph, Market Overview